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Abstract 
The experiments in this paper identify multiple calcium compartments in cultured human fibroblasts and reveal abnormalities in one of 
these pools in cells from Alzheimer patients. In the presence of external calcium, bradykinin (BK) increased cytosolic free calcium 
([ Ca2+ ]i) about 3-fold and then [Ca 2+ ]i rapidly declined. Omission of calcium from the media did not affect he BK-induced peak, which 
indicates that the peak reflects internal stores. Other compounds that also released calcium from internal stores included A23187 (a 
calcium ionophore), thapsigargin (Tg; an inhibitor of endoplasmic reticulum ATPase), and FCCP (an uncoupler of oxidative phosphoryla- 
tion). The [Ca2+] i response to sequential addition of compounds in calcium-free media identified discrete internal calcium stores. BK 
depleted internal calcium pools such that subsequent s imulation with B K, FCCP or bombesin did not increase [Ca 2+ ]i. However, A23187 
or thapsigargin still elicited responses. A23187 depleted essentially all internal calcium pools. Either Tg or FCCP reduced the calcium 
stores that could be released by BK or A23187. Thus, cellular calcium compartments that respond to BK and A23187 partially overlap. 
The common pool includes Tg- and FCCP-sensitive compartments. Calcium stores were examined in cells from Alzheimer disease 
patients, because previous tudies suggest that their calcium homeostasis is altered. A23187 addition to BK-treated cells produced a 95% 
greater esponse in cell lines from Alzheimer patients (n = 7) than in those from controls (n = 5). Thus, various calcium stores can be 
pharmacologically distinguished in fibroblasts and at least one of these compartments is abnormal in Alzheimer's disease. 
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1. Introduction 
Although assessment of cytosolic free calcium ([Ca 2+ ]i) 
is now routine in many laboratories throughout the world, 
evaluation of calcium in cellular compartments i still 
difficult and indirect. Cellular calcium compartments can 
be an important source of calcium following stimulation 
(e.g., release of calcium from the endoplasmic reticulum) 
and, in addition, the calcium concentrations within these 
organelles can regulate calcium-dependent processes. Two 
well-documented examples of the latter are processing of 
proteins in the endoplasmic reticulum [1] and mitochon- 
drial oxidation [2,3]. Cross talk exists between these vari- 
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ous calcium compartments. For example, in some cell 
types depletion of non-nuclear pools can arrest cell divi- 
sion [4]. In some preparations, such as synaptosomes, 
external calcium can be the major source of the elevated 
calcium that accompanies timulation [5]. However, in 
many cellular systems, the primary calcium response to 
stimulation is from internal stores and external calcium is 
only required for refilling depleted internal calcium pools 
[6]. Thus, in the absence of external calcium, changes in 
[ Ca2+ ]i can be used to monitor internal calcium stores. In 
the current studies, the internal calcium compartments 
were evaluated in calcium-free media by sequential addi- 
tion of compounds that interact with various calcium stores. 
Bradykinin (BK) activates phospholipase C and subse- 
quently releases IP 3 to release internal calcium stores. 
BK-sensitive pools were depleted and then the following 
drugs were added to test whether additional calcium stores 
could be released: FCCP (an uncoupler of oxidative phos- 
phorylation that collapses the mitochondrial membrane 
potential and releases mitochondrial calcium), thapsigargin 
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(an inhibitor of the endoplasmic reticulum ATPase), 
A23187 (a calcium ionophore) or bombesin (an activator 
of IP 3 production by a different mechanism than BK). This 
approach allowed delineation of discrete calcium pools 
within fibroblasts. 
Several studies suggest that calcium homeostasis is 
altered in fibroblasts from Alzheimer's Disease (AD) pa- 
tients. Recent reports indicate that the abnormal gene in 
the majority of Alzheimer families (i.e., early-onset AD) is 
related to 'calcium cycling' within cellular organelles [7]. 
Previous tudies report a reduced 45Ca uptake [8]. Whether 
a consistently altered response to stimulation occurs in AD 
fibroblasts has proven difficult to document. Although 
enhanced sensitivity of [Ca 2+ ]i to bombesin or BK [9] has 
been found in AD fibroblasts, the response of [Ca 2+ ]i to 
stimulation is controversial. Published reports show de- 
creases [10-12], increases [13] or no change [14,15]. 
Whether or not resting [Ca 2+ ]i changes in AD cells is also 
controversial [10,14,15]. A possible explanation for the 
lack of reproducible modifications with AD is that internal 
calcium stores have been variably altered by unique ma- 
nipulations in the various laboratories. Thus, in the current 
studies the internal stores of calcium in fibroblasts from a 
young control are characterized and then one of these 
internal pools is compared in fibroblasts from Alzheimer 
patients and age-matched controls. 
2. Materials and methods 
2.1. Materials 
Cultured human fibroblasts were from the Coriell Insti- 
tute for Medical Research (Camden, NJ). Fura-2AM and 
4-Br-A23187 were from Molecular Probes (Eugene, OR). 
Dulbecco's modified Eagle's medium (DMEM) and fetal 
bovine serum (FBS) were from Gibco Laboratories (Grand 
Island, NY). Bradykinin (BK), thapsigargin (Tg), carbonyl 
cyanide p-trifluoromethoxy)phenylhydrazone (FCCP), 
Hepes and EGTA were from Sigma Chemical Co. (St. 
Louis, MO). Bovine albumin fraction V was from United 
States Biochemical Corp. (Cleveland, OH). 
2.2. Methods 
2.2.1. Cell culture 
Fibroblasts were routinely maintained in DMEM sup- 
plemented with 10% FBS and incubated at 37°C in a 
humidified atmosphere with 5% CO 2 in air. For the exper- 
iments, confluent cells were subcultured onto 25 mm 
round glass cover slips at a density of 1 • 10 4 cells/cm 2. 
The comparison of multiple cell lines required that all lines 
be maintained under highly controlled conditions [16]. 
A cell line from an apparently normal, young male 
donor (GM03652, 24 yr) was grown for 3-4 days after 
subculturing. One day before the experiment the growth 
medium was removed and the cells were rinsed and incu- 
bated in serum-free DMEM for 24 h. Since some of the 
cell lines from age-matched control and AD donors did not 
reach confluence in 3-4 days, the cell lines for these 
comparisons were allowed to grow for seven days and 
were not serum-deprived until the day of the experiment. 
The age-matched control cell lines consisted of four appar- 
ently normal donors (AG03524, AG09878, GM04260, 
AG06010) and one escapee from the Canadian pedigree 
(AG07657) with an average age of 66 + 6 yr. An escapee 
is an individual in that family who has passed the age of 
onset for AD without symptoms of the disease. The 
Alzheimer cell lines included three donors from the Cana- 
dian pedigree (AG06848, AG06840, AG04159) and four 
other confirmed Alzheimer donors (AG05809, AG04400, 
AG07377, AG04401) with an average age of 55 + 2 yr. 
All cell lines were used at similar passage numbers. The 
studies were done with cells that had cumulative popula- 
tion doubling level of less than 30. In general, these cell 
lines stop dividing (i.e., phase out) at a cumulative popula- 
tion doubling level of 43. Whether the donor has AD does 
not affect the cumulative population doubling level to 
phase out [17-19]. 
2.2.2. Incubation media 
Two different incubation media were used for the ex- 
periments on calcium regulation in the cell line from the 
young donor. The control incubation medium was DMEM 
with 20 mM-Hepes and 1% BSA similar to the loading 
medium (see below) and had a calcium concentration of
1.8 raM. Calcium-free medium was made by adding 2.5 
mM-EGTA to the control medium, and adjusting the pH to 
7.4 at 37°C. This provides a calculated calcium concentra- 
tion of 116 nM (MaxChelator v 6.63; Chris Patton, Stan- 
ford University, Hopkins Marine Station, Pacific Grove, 
CA 93950-3094). 
2.2.3. [Ca 2 + ]i measurements 
Fibroblasts were loaded with 2 /zM Fura-2AM in 
DMEM with 20 mM-Hepes and 1% bovine serum albumin 
(loading medium) for one hour at room temperature to
prevent the sequestration of the dye in organelles 
[14,20,21]. After the loading incubation, the coverslip was 
rinsed three times with 37°C medium that was the same as 
above except hat the Fura-2AM was omitted. Even under 
high magnification, o punctate fluorescence was apparent. 
Furthermore, xcitation scans of these cells showed that no 
unhydrolyzed fura-2AM was present in the cells. All ex- 
periments were performed at 37°C. The cover slips were 
secured in a Leiden coverslip dish and placed on a temper- 
ature controlled (37°C) micro-incubator with 2 ml incuba- 
tion medium. The micro-incubator was mounted onto the 
stage of an Olympus inverted microscope quipped with a 
Nikon 40X UV Fluor objective lens. To minimize the 
temperature gradient between different parts of the cover- 
slip, the micro-incubator was continuously gassed with 5% 
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CO2/95% air at a flow rate of 3 standard cubic feet/h 
[22]. 
These studies utilized a photometric method in which 
the signal from a microscope field was detected with a 
photomultiplier tube as opposed to imaging. This allowed 
us to average the response of the field that included up to 
six cells. Since the approach is much faster than imaging, a 
continuous monitoring of the response to stimulation can 
be made. Calcium measurement was initiated after a 3-rain 
equilibration period by alternately exciting the cells with 
350 and 380 nm wavelengths five times per second using a 
PTI Delta scan (Photon Technology International; S. 
Brunswick, NJ) and emission was measured at 510 nm. 
Treatments were done by removing about 90% of the 
incubation medium and then adding it to the drug. The 
solution was then reapplied to the cells. These manipula- 
tions required less than 10 s. Three to four samples were 
run for each experimental group or cell line on a given day 
and the experiments were repeated on at least two separate 
days. [Ca 2+ ]i was calculated by the method of Grynkewicz 
et al. [23] after correction for background fluorescence. 
2.2.4. Statistical analysis 
Statistical analysis was by analysis of variance followed 
by Student-Newman-Keuls' test with software from SPSS 
Inc (Chicago, IL). 
3. Results 
The effects of external calcium on the temporal re- 
sponse of [Ca2+]i to BK were determined (Fig. 1). Our 
previous results [14,20] demonstrate hat 10 nM-BK is the 
optimal concentration to resolve the effects of various 
treatments on the magnitude and time of peak response. In 
medium with normal calcium (1.8 raM), 10 nM-BK imme- 
diately increased [Ca2+]i 2.6 fold and then [Ca2+] i de- 
clined to a new equilibrium value that was 36% higher 
than the baseline after three minutes. Removal of calcium 
at the time of BK stimulation (acute) did not alter the basal 
[Ca2+]i (91 + 1 nM (control) vs. 88 _ 1 nM (acute)), time 
to peak (13+ 1 s) nor the peak [Ca2+]i (325+22 nM 
(control) vs. 334+ 21 nM (acute)), but eradicated the 
sustained increase above baseline (143 __+ 2 nM (control) 
vs. 83 + 4 nM (acute) at 3 min after stimulation; P < 0.05). 
Similarly, reduction of the calcium immediately after fura 
loading (short term): (1) slightly, but significantly, dimin- 
ished resting [Ca2+]~ (from 9l ___ l nM to 82 + 1 nM; 
P < 0.05), (2) did not significantly reduce the peak [Ca 2+ ]i 
and (3) abolished the sustained increase after the peak. 
Thus, the  [Ca2+]i  peak after BK was largely independent 
of external calcium, while the sustained elevation after BK 
required external calcium. For subsequent experiments, 
'short term' was used rather than acute because it is 
technically easier to control temperature and calcium. 
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Fig. 1. The temporal response of cellular [Ca 2+ ]i to bradykinin (10 nM) 
without external calcium at the time of stimulation (acute) or for 5 min 
(short erm). The calcium in the control medium (1.8 mM) was decreased 
to calcium-free (i.e., control medium + 2.5 mM-EGTA) either at the time 
of BK-stimulation (acute) or immediately after loading with fura-2 (short 
term). Cells from the young donor were loaded as described in 'Methods'. 
The tracing for each treatment is the average of 8 samples that were run 
on two different days. On each experimental day, all of the samples from 
each treatment were measured alternately to prevent any bias. For statisti- 
cal comparisons, values (means +S.E.) were calculated at multiple time 
points. Control values (nM) were basal (91 ___ 1), peak after BK (325 + 22), 
60 s after BK (182_+4), 120 s after BK (152_+2) and 180 s after BK 
(143 ± 2). The time to peak in controls was 13 + 1 s and did not vary with 
treatment. 
duced peak of  [Ca2+] i was primarily related to internal 
calcium compartments provided a method to evaluate in- 
ternal stores. The calcium-free media was used in the 
rinses and all subsequent s eps after the fura-2 loading as 
described for the 'short term' incubations in Fig. 1. The 
basic design of the experiments was that an agent was 
added to release the internal calcium stores that were 
sensitive to that drug. The compound was left in the media 
to block the refilling of that particular calcium pool. The 
effects of subsequent addition of other drugs were then 
determined to delineate various calcium stores. 
To characterize BK-insensitive calcium pools, cells were 
stimulated with BK in calcium-free medium to deplete 
BK-sensitive stores and then subsequently treated with 
either BK, thapsigargin, FCCP, A23187 or bombesin (Fig. 
2). When used as the initial drug, 10 nM-BK increased 
[Ca2+ ]i by 304 ___ 20% over basal with a peak time = 16 + 
3 s (n = 6). By two min [Ca2+] i returned to baseline. This 
concentration of BK completely blocked subsequent s imu- 
lation with 10 nM-BK as long as BK was still present in 
the media. If BK was removed and the cells were re- 
stimulated with BK, a small response was elicited (results 
not shown). If BK was followed by A23187, a second 
peak occurred that was 54 + 13% (n = 6) above the 3-min 
value (Fig. 2). Thapsigargin caused a 46 + 12% (n = 7) 
elevation, whereas no increase was observed with FCCP 
(n = 4) or bombesin (n = 6). Clearly, releasable internal 
stores of calcium persist after BK stimulation. 
To test whether the BK-insensitive, but Tg- or 
A23187-sensitive pools were a function of the initial con- 
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Fig. 2. Characterization f BK-insensitive internal calcium stores. Cells in 
calcium-free media were first stimulated with BK. The response paral- 
leled the 'short erm' tracing in Fig. 1. This tracing only shows the last 40 
of the response after bradykinin. 3 min after BK either A23187 (20/xM; 
n = 6), FCCP (10 tzM; n = 4), bombesin (1 /xM; n = 6) or thapsigargin 
(100 nM; n = 7) was added. Each tracing is the average of the number of 
samples indicated in parentheses. No response was observed after a 
second addition of BK. 
centration of BK, multiple BK concentrations were added 
before Tg or A23187 (Fig. 3). The [Ca 2÷ ]i, response to the 
indicated concentration of BK was determined (Q). In- 
creasing the BK concentrations released progressively more 
[ Ca2÷ ]i from the BK sensitive pool The maximal peak was 
at 1 ~M-BK and the response declined at higher concen- 
trations. The effect of 100 nM Tg after each concentration 
of BK was determined (/x ). The BK-insensitive, TG-sensi- 
tive pool did not decline significantly once the BK concen- 
trations were higher than 10 nM. The response to 20 /zM- 
A23187 after each concentration of BK was also deter- 
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Fig. 3. Characterization f BK-insensitive but Tg- or A23187- sensitive 
internal calcium stores. BK was added at the indicated concentration. The 
Q represents he initial BK peak. 3 min later, Tg (100 nM) or A23187 
(20 ~M) were added. The [] represents the A23187 peak after the 
addition of BK. The zx represents he Tg peak after the addition of BK. 
partment persisted at all concentrations of BK that were 
tested. 
The response of internal calcium pools to stimulation 
with the calcium ionophore A23187 was also charac- 
terized. Experiments were designed to determine if A23187 
released all calcium stores from the fibroblasts, because 
A23187 released a significant amount of calcium after BK. 
The responses to 2, 10 and 20/zM-A23187 were evaluated 
to determine which concentration should be used. Two 
/zM-A23187 increased [Ca2+] i about 40%. Ten and 20 
/zM-A23187 increased [Ca2+]i more than 2 /zM and the 
increase was similar at both concentrations (330-350%; 
Data not shown). Because the response at 20 /zM was no 
greater than 10 ~M, 20 /xM-A23187 was found to be 
saturating and was used to characterize A23187 sensitive 
stores. The 20 /xM-A23187 peak was about 10% larger 
than the peak after BK addition and returned to baseline 
more slowly (3 min) than following BK (2 min) and 
continued to slowly decrease. The subsequent addition of 
BK or FCCP did not increase [Ca2+]i above the 3 min 
value. Tg caused a small increase in [Ca2+] i. Tg after 
A23187 increased [Ca 2÷ ]i by a maximum of 4.4 + 0.7%. 
Thus, A23187 depleted essentially all releasable calcium 
stores. 
To determine if any of the Tg-releasable calcium pool 
overlapped the A23187 and BK compartments, he effects 
of Tg on the BK- or A23187-stimulated increase in [Ca 2÷ ]i 
was determined. Thapsigargin gradually increased [Ca2+]j 
(Fig. 4). The maximal change was observed after 120 + 4 
s compared to peaks at about 15 s with BK or A23187. 
The increase over the baseline was 62.2 -t- 2.5% (n = 14). 
[ Ca2÷ ]i did not return to baseline for 10 minutes. Although 
[Ca2+ ]i was still 51 + 2% above basal at 3 min, the second 
stimulation was done three minutes after Tg to allow 
comparison with the experiments on A23187 and BK. 
Preliminary studies showed that the BK-response was sim- 
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Fig. 4. Characterization of thapsigargin (Tg)-sensitive internal calcium 
compartment and its relation to BK and A23187-sensitive stores. Cells 
were stimulated with Tg (100 nM) and 3 min later either BK (10 nM; 
n = 7) or A23187 (20 /zM;  n = 7) was  added. Each tracing is the average  
of the number of samples indicated in parentheses. 
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Fig. 5. Characterization f the FCCP-sensitive calcium compartment and 
its relation to BK and A23187-sensitive stores. Cells were stimulated with 
FCCP (10/xM) and 3 min later either BK (10 nM; n = 4) or A23187 (20 
/xM; n = 5) was added. Each tracing is the average of the number of 
samples indicated in parentheses. Table 1. Altered internal calcium stores 
in fibroblasts from Alzheimer donors and age-matched controls• 
Prior addition of Tg reduced the BK-induced change in 
[Ca2+]i from 272 + 25 nM (above basal) to 201 -t- 12 nM 
(i.e., about a 26% reduction; n = 7; P = 0.008). In the 
same manner, Tg reduced the A23187-induced increase in 
[Ca2+] i from 306 _+ 16 nM to 179 _+ 20 nM (i.e., a 41% 
reduction; n = 7; P = 0.0001). Thus, Tg diminished the 
BK- and A23187-releasable stores of calcium. 
Although FCCP did not release calcium following ei- 
ther BK (Fig. 2) or A23187 (Fig. 4; data not shown), 
FCCP releases calcium from internal stores (Fig. 5). Thus, 
to test if the FCCP-releasable calcium pool overlapped the 
A23187 or BK compartments, the effects of FCCP on the 
BK- or A23187-stimulated increase in [Ca 2+ ]i were deter- 
mined. FCCP had a less profound effect on [Ca2+] i than 
the other compounds that were tested (Fig. 5). FCCP 
gradually increased [Ca 2+ ]i by 20.5 + 3% (n = 9) after 3 
min. To allow comparison with the results on the BK- and 
A23187-sensitive compartments previously discussed, BK 
or A23187 was added three minutes after FCCP. The prior 
addition of FCCP reduced the maximal BK-induced in- 
crease from 321 ___ 17 nM to 239_+ 16 nM (i.e., a 26% 
reduction; P = 0.004). Prior stimulation with FCCP dimin- 
ished the response to A23187 from 321 + 42 nM to 261 + 
16 nM (i.e., a 19% reduction). Thus, although FCCP did 
not alter [Ca2+] i by very much, it diminished both BK- 
and A23187-releasable calcium pools. 
Calcium stores in fibroblasts from Alzheimer patients 
differed from controls (Table 1). Basal values and the 
changes in [Ca 2+ ]i following BK stimulation were identi- 
cal in control and Alzheimer fibroblasts, in agreement with 
our previous studies [14,20]. However, the response to 
stimulation with A23187 following BK was exaggerated in 
the Alzheimer cells. If control cells were first stimulated 
with BK, the second stimulation with A23187 increased 
[Ca2+]i from 90+4 nM to 126+7 nM (i.e., a 40% 
increase), whereas the [Ca2+] i in the Alzheimer cells 
increased from 87 _ 4 nM to 153 ___ 17 nM (i.e., a 77% 
increase). The percent increase in the Alzheimer cells was 
92% greater than in the controls. 
4. Discussion 
The results demonstrate that manipulation of [Ca2+]~ 
after an initial stimulation with BK, Tg, FCCP or A23187 
can clearly distinguish internal calcium stores. Multiple 
studies have examined calcium compartments in cultured 
fibroblasts [6,24]. Generally, these experiments concen- 
trated on how these pools - particularly BK sensitive 
compartments - are refilled after depletion of internal 
stores [6]. Those results demonstrate that BK and iono- 
mycin deplete BK-sensitive calcium pools and that refill- 
ing of these stores requires extracellular calcium. The 
Table 1 
Altered internal calcium stores in fibroblasts 
Line 
from Alzheimer donors and age-matched controls 
Age Basal [Ca 2 + ]i A [Ca 2 -- ]i 
after BK 
Basal [Ca 2 + ]i A [Ca 2 + ]i 
3 rain after BK after A23187 
Aged control 
Alzheimer 
7657 ~ a 88 96+2 497_+51 102±3 40±26 
6010 9 53 90 + l 458 ___ 47 92 ± 7 34 + 1 
3524 Q 67 92 + 3 360 + 53 92_+ 7 42 + 4 
9878 9 61 83 + 2 286 + 51 80 ± 8 38 + 8 
4260 6 60 77 + 1 215 + 21 85 + 13 23 + 1 
mean ± S.E. 66 + 5 88 + 4 363 ± 58 90 _+ 4 36 ± 4 
5809 ~ 63 91 ± 3 380___ 120 88 ± 3 88 ± 8 
4400 q~ 61 86 + 6 302 ± 75 93 ± 24 94 _+ 62 
6848 ~ a 55 81±2 476±65 75_ 1 43±16 
7377 ~ 47 79_+ 12 272 ± 50 81 ± 14 46 + 18 
6840 ~ a 56 80±3 330±88 77+5 40±5 
4159 9 " 52 105 ± 2 365 ± 138 101 ± 3 122 + 1 
4401 c? 53 91±6 446±89 89±7 39_+3 
mean ± S.E. 55 ± 2 88 ± 4 367 ± 30 87 ± 4 67 ± 14 b 
a Cell lines from the Canadian family with the chromosome 14 defect [7]• 
b Denotes that AD cells are significantly (P = 0.023) higher than controls. Cells were first stimulated in calcium-free media with BK. The response 
paralleled the 'short erm' tracing in Fig. 1.3 min after BK, A23187 (20 /xM) was added. Each cell line was evaluated on multiple days and a median 
value for each measurement was obtained for that day. The values in the table are means + S.E. of the daily medians. 
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current studies revealed multiple calcium pools and their 
interactions by examining the effects on [Ca2+]i after 
releasing one pool and then testing the effects of subse- 
quent stimulation with BK, A23187, thapsigargin, 
bombesin or FCCP. Although some of the changes in 
[ Ca2÷ ]i with the addition of the second drug were small, 
they likely reflect large changes in particular subcellular 
compartments. Even though the compartments can be 
clearly defined, the size of the various calcium pools is 
more difficult to determine. This is shown by the observa- 
tion that Tg and FCCP do not release much calcium but 
diminish the release of calcium after BK or A23187 to a 
considerable xtent. Morphological correlates of these 
pools cannot be assigned, because none of the compounds 
that we examined are absolutely specific. 
The manipulation of [Ca2+] i following BK revealed 
multiple compartments. The peak after BK clearly reflects 
internal stores under the conditions of these experiments 
(short time intervals and calcium-free media). This agrees 
with previous results of our own [14,20] and others [6]. 
Bombesin and bradykinin appeared to release the same 
calcium pools, since bombesin was inactive after 
bradykinin addition and produced a large peak if no BK 
was present. Although BK released most of the calcium 
from the A23187 compartment, A23187 still released cal- 
cium after BK addition. This is clear evidence of a BK-in- 
sensitive, A23187-sensitive pool of calcium in fibroblasts. 
Following BK, Tg released nearly as much calcium as 
A23187. Although Tg alone did not release much calcium, 
Tg addition before BK diminished the action of BK. If the 
Tg and BK calcium pools were separate, an additive action 
would have occurred. Since BK is not generally considered 
to act on mitochondria, the observation that BK released 
all of the calcium in the FCCP-sensitive pool was surpris- 
ing. Although FCCP alone did not release much calcium, it 
diminished the effects of BK. If the FCCP and BK calcium 
pools were separate, the prior addition of FCCP would not 
diminish the BK response. These results demonstrate con- 
siderable interaction of these various pools. 
Sequential addition of the various compounds after 
A23187 also revealed multiple calcium pools. The entire 
BK-sensitive compartment was released by A23187. Al- 
though Tg after A23187 released minimal calcium, Tg 
addition before A23187 diminished the action of A23187 
considerably. This suggests that there is a large Tg-sensi- 
tive compartment that overlaps A23187-sensitive stores. If 
the Tg and A23187 sensitive store were separate, prior 
addition of Tg would not be expected to diminish the 
A23187 response. A23187 released all of the calcium in 
the FCCP-sensitive pool. Although FCCP alone did not 
release much calcium, it diminished the effects of A23187. 
If the FCCP and A23187 pools were separate, an additive 
effect of the drugs on [Ca 2+ ]i would have been apparent. 
Mitochondrial stores of calcium in cultured fibroblasts 
have not been previously examined. FCCP collapses mito- 
chondrial proton gradients and diminishes the mitochon- 
drial membrane potential. Our previous tudies in synapto- 
somes show that FCCP reduces the mitochondrial mem- 
brane potential and diminishes their ability to buffer cal- 
cium from outside the cell [25]. The current studies only 
examined the interaction of the mitochondrial calcium with 
other internal pools. The lack of an increase in [Ca2+] i 
with FCCP after BK or A23187 suggests that both BK and 
A23187 release some mitochondrial pools of calcium. The 
observation that FCCP reduces both the A23187- and 
BK-induced elevation of [Ca 2+ ]i further supports this pos- 
sibility. Methods are now evolving to directly study mito- 
chondrial calcium [26] so that this hypothesis can be 
tested. Although considerable vidence suggests that an 
oxidative deficit accompanies AD [27], the current experi- 
ments did not test whether mitochondrial calcium stores 
were abnormal in AD fibroblasts. 
The current studies demonstrate hat internal calcium 
pools are altered in fibroblasts from Alzheimer patients. 
The stores that are not released by BK, but are released by 
A23187, are substantially elevated in Alzheimer fibrob- 
lasts. The compartment that is altered by AD probably 
does not reflect he mitochondrial compartment, since BK 
releases the mitochondrial store (i.e., FCCP sensitive) and 
the calcium compartment that is altered in AD is BK 
insensitive. Previous reports of altered calcium regulation 
in Alzheimer fibroblasts are controversial [see summary in 
[28]]. They disagree on whether agonist stimulated changes 
in [Ca2+] i are elevated [13], decreased [10-12] or not 
changed [14,15]. A reasonable xplanation of these diffi- 
culties in replication is that the internal stores of calcium 
were variably loaded and released in various laboratories. 
Since the calcium content of internal stores can regulate 
the rate of calcium uptake [29], the current results that 
show increased calcium in internal stores are consistent 
with our original observation that showed diminished up- 
take of 45Ca [8] and the studies that showed increased 
calcium content in these cells [11]. Further support for 
altered internal calcium stores in AD fibroblasts is shown 
by findings that demonstrate bombesin-releasable calcium 
pools are larger in AD fibroblasts and that AD fibroblasts 
are more sensitive than controls to pM concentrations of
BK [9]. Complete lucidation of the AD-related changes in 
calcium regulation requires comparison of the other cal- 
cium compartments. Recent studies uggest that the abnor- 
mal gene in AD families with chromosome 14 linkage (the 
lines listed as Canadian in this study) codes for a protein 
that is likely to be involved in calcium cycling in intemal 
stores [7]. Thus, the current approach will be useful to 
examine the pathophysiological importance of this gene 
defect. 
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